We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer.
- Authors
Kelley, R K; Hwang, J; Magbanua, M J M; Watt, L; Beumer, J H; Christner, S M; Baruchel, S; Wu, B; Fong, L; Yeh, B M; Moore, A P; Ko, A H; Korn, W M; Rajpal, S; Park, J W; Tempero, M A; Venook, A P; Bergsland, E K
- Abstract
This phase 1 clinical trial was conducted to determine the safety, maximum-tolerated dose (MTD), and pharmacokinetics of imatinib, bevacizumab, and metronomic cyclophosphamide in patients with advanced colorectal cancer (CRC).
- Publication
British journal of cancer, 2013, Vol 109, Issue 7, p1725
- ISSN
1532-1827
- Publication type
Journal Article
- DOI
10.1038/bjc.2013.553